Batch Release Test | Vanta BioScience

Batch Release Pharmacopoeia Tests (USP, BP, and IP)

Pharmacopoeia standards are publicly available and legally enforceable standards of quality for medicinal products and their constituents, used by individuals and organizations involved in pharmaceutical research, development, manufacture and testing. These standards are used by regulatory agencies and manufacturers to ensure that these products are of the appropriate identity, as well as strength, quality, purity, and consistency.

The British Pharmacopoeia (BP) is an annual published collection of quality standards for UK medicinal substances, which complements and assists the licensing and inspection processes of MHRA, UK. The United States Pharmacopeia (USP) is the official pharmacopeia of the United States, published dually with the National Formulary as the USP-NF. The standards set in the USP-NF are mandatory for prescription and over-the-counter medicines and other health care products sold in the United States. Indian Pharmacopoeia Commission (IPC) is the official drug administration agency of India.

Vanta Bioscience currently offers the following services required under batch release pharmaceutical quality control requirements as per the relevant pharmacopoeia:

Pyrogen testing
Stability studies
Abnormal toxicity and impurity profiling